rosiglitazone has been researched along with thioctic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boscaro, M; Grossman, AB; Kola, B; Korbonits, M; Rutter, GA | 1 |
| Chen, A; Deng, W; Fang, D; Huang, Z; Li, H; Li, Y; Liu, J; Liu, L; Wan, X; Wei, G | 1 |
1 review(s) available for rosiglitazone and thioctic acid
| Article | Year |
|---|---|
Expanding role of AMPK in endocrinology.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Appetite Regulation; Cannabinoids; Cytokines; Endocrine System; Fatty Acid Synthases; Ghrelin; Glucose; Humans; Hypothalamic Hormones; Insulin; Leptin; Metformin; Models, Biological; Multienzyme Complexes; Peptide Hormones; Protein Serine-Threonine Kinases; Receptors, Adrenergic; Resistin; Rosiglitazone; Thiazolidinediones; Thioctic Acid | 2006 |
1 trial(s) available for rosiglitazone and thioctic acid
| Article | Year |
|---|---|
Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant α-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus.
Topics: Adult; Aged; Antioxidants; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Insulin-Secreting Cells; Lipids; Male; Malondialdehyde; Metformin; Middle Aged; Rosiglitazone; Thiazolidinediones; Thioctic Acid; Time Factors | 2013 |